WO2007063335A3 - Amphotericin b salt - Google Patents

Amphotericin b salt Download PDF

Info

Publication number
WO2007063335A3
WO2007063335A3 PCT/GB2006/004514 GB2006004514W WO2007063335A3 WO 2007063335 A3 WO2007063335 A3 WO 2007063335A3 GB 2006004514 W GB2006004514 W GB 2006004514W WO 2007063335 A3 WO2007063335 A3 WO 2007063335A3
Authority
WO
WIPO (PCT)
Prior art keywords
amphotericin
salt
meglumine
provides
molar ratio
Prior art date
Application number
PCT/GB2006/004514
Other languages
French (fr)
Other versions
WO2007063335A2 (en
Inventor
Jo Klaveness
Original Assignee
Drug Discovery Lab As
Cockbain Julian
Jo Klaveness
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drug Discovery Lab As, Cockbain Julian, Jo Klaveness filed Critical Drug Discovery Lab As
Priority to EP06820400A priority Critical patent/EP1960412A2/en
Publication of WO2007063335A2 publication Critical patent/WO2007063335A2/en
Publication of WO2007063335A3 publication Critical patent/WO2007063335A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The invention provides a salt of amphotericin B and meglumine in which the molar ratio of amphotericin B to meglumine is about 1:1.
PCT/GB2006/004514 2005-12-02 2006-12-04 Amphotericin b salt WO2007063335A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06820400A EP1960412A2 (en) 2005-12-02 2006-12-04 Amphotericin b salt

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0524685.5 2005-12-02
GBGB0524685.5A GB0524685D0 (en) 2005-12-02 2005-12-02 Compound

Publications (2)

Publication Number Publication Date
WO2007063335A2 WO2007063335A2 (en) 2007-06-07
WO2007063335A3 true WO2007063335A3 (en) 2007-09-20

Family

ID=35686013

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/004514 WO2007063335A2 (en) 2005-12-02 2006-12-04 Amphotericin b salt

Country Status (3)

Country Link
EP (1) EP1960412A2 (en)
GB (1) GB0524685D0 (en)
WO (1) WO2007063335A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012012782A1 (en) 2010-07-23 2012-01-26 Acea Biotech, Inc. Antifungal and antiparasitic polyene macrolides
DE102014012022A1 (en) * 2014-08-13 2016-02-18 Clariant International Ltd. Organic ammonium salts of anionic pesticides

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1430886A (en) * 1974-05-01 1976-04-07 Le Nii Antibiotikov Meglumine compolexes of fungicidal polyene antibiotics-macrolides
US4002741A (en) * 1974-04-24 1977-01-11 Valter Osvaldovich Kulbakh Meglumine complex fungicidal polyene macrolide antibiotic compositions and treatment method
US5942495A (en) * 1996-05-10 1999-08-24 Btg International Limited Antibiotics

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002741A (en) * 1974-04-24 1977-01-11 Valter Osvaldovich Kulbakh Meglumine complex fungicidal polyene macrolide antibiotic compositions and treatment method
GB1430886A (en) * 1974-05-01 1976-04-07 Le Nii Antibiotikov Meglumine compolexes of fungicidal polyene antibiotics-macrolides
US5942495A (en) * 1996-05-10 1999-08-24 Btg International Limited Antibiotics

Also Published As

Publication number Publication date
GB0524685D0 (en) 2006-01-11
WO2007063335A2 (en) 2007-06-07
EP1960412A2 (en) 2008-08-27

Similar Documents

Publication Publication Date Title
IL187453A0 (en) The preparation and uses of compounds as aspartyl protease inhibitors
WO2005092871A3 (en) Intermediates for the preparation of pramipexole
PL378587A1 (en) Methods of (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazole and/or its salts
WO2006049734A3 (en) Quetiapine analogs and methods of use thereof
WO2006034414A3 (en) Loxapine analogs and methods of use thereof
WO2006040574A3 (en) Lipocalin protein
GB0307671D0 (en) Improvements relating to the construction of playing surfaces
ZA200805711B (en) Solid biocidal compositions and methods of using the same
EP1898940A4 (en) Inhibitors of the alpha2beta 1/gpia-iia integrin
HK1079776A1 (en) The synthesis of 1,3-dihydro-2h-3-benzazepin-2-onecompounds, and the use thereof
IL191067A0 (en) Micronised azodicarbonamide, the preparation and use thereof
WO2007063335A3 (en) Amphotericin b salt
WO2006095173A3 (en) Medical uses of 39-desmethoxyrapamycin and analogues thereof
EP1960510A4 (en) Ammonia-specific 5'-xmp aminase mutant
WO2006131515A3 (en) Stabilised il-21 compositions
GB2396117B (en) Improvements relating to the construction of playing surfaces
AU2006315663A8 (en) KIFS as modifiers of the RHO pathway and methods of use
WO2007035964A3 (en) Vigabatrin bioisoteres and related methods of use
AU2005904783A0 (en) Jacob's games
AU2004905208A0 (en) The Beat Discoteque
AU2004904460A0 (en) Further Improvements to the Versatile Fastener
AU2004902934A0 (en) Super improved fastener
AU2004900303A0 (en) Improvements relating to decreasing the spread of weeds
GB0423300D0 (en) Compositions and uses thereof, and preparation of the same
GB0406406D0 (en) 2149 reductase

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006820400

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06820400

Country of ref document: EP

Kind code of ref document: A2

WWP Wipo information: published in national office

Ref document number: 2006820400

Country of ref document: EP